Next Article in Journal
NK Cells as Potential Targets for Immunotherapy in Endometriosis
Previous Article in Journal
Maternal Obesity and Offspring Long-Term Infectious Morbidity
Open AccessReview

Ophthalmological Findings in Mucopolysaccharidoses

1
Department of Ophthalmology and Visual Sciences, University of Illinois at Chicago, Chicago, IL 60607, USA
2
Ophthalmic Clinic, Bürgerhospital, 60318 Frankfurt, Germany
3
Department of Ophthalmology, University Medical Center, Johannes Gutenberg University, 55131 Mainz, Germany
*
Author to whom correspondence should be addressed.
J. Clin. Med. 2019, 8(9), 1467; https://doi.org/10.3390/jcm8091467
Received: 12 August 2019 / Revised: 2 September 2019 / Accepted: 12 September 2019 / Published: 14 September 2019
(This article belongs to the Section Ophthalmology)
The mucopolysaccharidoses (MPS) are a heterogenous group of lysosomal storage disorders caused by the accumulation of glycosaminoglycans (GAGs). The accrual of these compounds results in phenotypically varied syndromes that produce multi-organ impairment with widespread systemic effects. The low incidence of MPS (approximately 1/25,000 live births) in conjunction with the high childhood mortality rate had limited the availability of research into certain clinical features, especially ocular manifestations. As the recent successes of hematopoietic stem cell transplantation (HSCT) and enzyme replacement therapy (ERT) have greatly increased life expectancy in these patients, they have served as a focal point for the transition of research towards improvement of quality of life. Ophthalmological findings in MPS include corneal clouding, glaucoma, optic neuropathies, and retinopathies. While corneal clouding is the most common ocular feature of MPS (especially type I, IVA, and VI), its response to HSCT and ERT is minimal. This review discusses known eye issues in the MPS subtypes, diagnosis of these ocular diseases, current clinical and surgical management, noteworthy research progress, and ultimately presents a direction for future studies. View Full-Text
Keywords: mucopolysaccharidosis; lysosomal storage disorder; ophthalmology; ocular manifestations; corneal clouding mucopolysaccharidosis; lysosomal storage disorder; ophthalmology; ocular manifestations; corneal clouding
Show Figures

Figure 1

MDPI and ACS Style

Tomatsu, S.; Pitz, S.; Hampel, U. Ophthalmological Findings in Mucopolysaccharidoses. J. Clin. Med. 2019, 8, 1467.

Show more citation formats Show less citations formats
Note that from the first issue of 2016, MDPI journals use article numbers instead of page numbers. See further details here.

Article Access Map by Country/Region

1
Search more from Scilit
 
Search
Back to TopTop